Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile: A randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance

Lipid Profile ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile: A Randomized, Placebo-Controlled, Double-Blind Trial of Supplementation in Subjects With Impaired Glucose Tolerance: Response to Gunton et al.

Diabetes Care ◽

10.2337/diacare.28.7.1841-a ◽

2005 ◽

Vol 28 (7) ◽

pp. 1841-1842 ◽

Cited By ~ 14

Author(s):

J. Komorowski ◽

V. Juturu

Keyword(s):

Insulin Sensitivity ◽

Glucose Tolerance ◽

Lipid Profile ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Tolerance Response ◽

Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile: A Randomized, Placebo-Controlled, Double-Blind Trial of Supplementation in Subjects With Impaired Glucose Tolerance: Response to Komorowski and Juturu

Diabetes Care ◽

10.2337/diacare.28.7.1842 ◽

2005 ◽

Vol 28 (7) ◽

pp. 1842-1843 ◽

Cited By ~ 1

Author(s):

J. E. Gunton ◽

N. W. Cheung ◽

R. Hitchman ◽

G. Hams ◽

C. Sullivan ◽

...

Keyword(s):

Insulin Sensitivity ◽

Glucose Tolerance ◽

Lipid Profile ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Tolerance Response ◽

Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile: A Randomized, Placebo-controlled, Double-blind Trial of Supplementation in Subjects With Impaired Glucose Tolerance

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70260-9 ◽

2006 ◽

Vol 2006 ◽

pp. 6-7

Author(s):

L. Kennedy

Keyword(s):

Insulin Sensitivity ◽

Glucose Tolerance ◽

Lipid Profile ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance

The Lancet ◽

10.1016/s0140-6736(09)60222-1 ◽

2009 ◽

Vol 373 (9675) ◽

pp. 1607-1614 ◽

Cited By ~ 190

Author(s):

Ryuzo Kawamori ◽

Naoko Tajima ◽

Yasuhiko Iwamoto ◽

Atsunori Kashiwagi ◽

Kazuaki Shimamoto ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glucose Tolerance ◽

Double Blind Trial ◽

Double Blind ◽

Effects of a New Combination of Nutraceuticals with Morus alba on Lipid Profile, Insulin Sensitivity and Endotelial Function in Dyslipidemic Subjects. A Cross-Over, Randomized, Double-Blind Trial

High Blood Pressure & Cardiovascular Prevention ◽

10.1007/s40292-015-0087-2 ◽

2015 ◽

Vol 22 (2) ◽

pp. 149-154 ◽

Cited By ~ 17

Author(s):

Valentina Trimarco ◽

Raffaele Izzo ◽

Eugenio Stabile ◽

Francesco Rozza ◽

Mario Santoro ◽

...

Keyword(s):

Insulin Sensitivity ◽

Lipid Profile ◽

Morus Alba ◽

New Combination ◽

Double Blind Trial ◽

Double Blind ◽

Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12620 ◽

2016 ◽

Vol 18 (7) ◽

pp. 711-715 ◽

Cited By ~ 9

Author(s):

A. O. Stirban ◽

M. Andjelkovic ◽

T. Heise ◽

L. Nosek ◽

A. Fischer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Sensitivity ◽

Glucose Control ◽

Peroxisome Proliferator ◽

Double Blind Trial ◽

Lipid Levels ◽

Double Blind ◽

Peroxisome Proliferator Activated Receptor ◽

Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension

BMJ Open ◽

10.1136/bmjopen-2015-008086 ◽

2015 ◽

Vol 5 (8) ◽

pp. e008086 ◽

Cited By ~ 5

Author(s):

Morris J Brown ◽

Bryan Williams ◽

Thomas M MacDonald ◽

Mark Caulfield ◽

J Kennedy Cruickshank ◽

...

Keyword(s):

Essential Hypertension ◽

Glucose Tolerance ◽

Double Blind Trial ◽

Double Blind ◽

99: Prulifloxacin Versus Levofloxacin in the Treatment of Chronic Bacterial Prostatitis: A Prospective, Randomized, Double-Blind Trial

The Journal of Urology ◽

10.1016/s0022-5347(18)30364-1 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 35-35

Author(s):

Gianluca Giannarini ◽

Andrea Mogorovich ◽

Girolamo Morelli ◽

Maurizio De Maria ◽

Francesca Manassero ◽

...

Keyword(s):

Double Blind Trial ◽

Chronic Bacterial Prostatitis ◽

Double Blind ◽

Blind Trial ◽

Bacterial Prostatitis

A Controlled, Randomized, Double-Blind Trial of Prophylaxis Against Jaundice Among Breastfed Newborns

Yearbook of Pediatrics ◽

10.1016/s0084-3954(08)70208-2 ◽

2007 ◽

Vol 2007 ◽

pp. 378-380

Author(s):

J.A. Stockman

Keyword(s):

Double Blind Trial ◽

Double Blind ◽

Ascorbic acid in pediatric and adolescent Charcot- Marie- Tooth Disease 1A – A placebo-controlled, double-blind trial in progress

Neuropediatrics ◽

10.1055/s-2008-1079579 ◽

2008 ◽

Vol 39 (01) ◽

Author(s):

O Schwartz ◽

B Fiedler ◽

M Schilling ◽

P Young ◽

G Kuhlenbäumer ◽

...

Keyword(s):

Ascorbic Acid ◽

Double Blind Trial ◽

Double Blind ◽

Charcot Marie Tooth ◽

Blind Trial ◽

Charcot Marie Tooth Disease ◽

Tooth Disease